Comparison of efficacy of add-on therapy of vildagliptin versus pioglitazone among type 2 diabetes mellitus patients inadequately controlled on dual therapy of …

K Kaur, R Kaur, N Mittal, S Arora… - Asian Journal of Medical …, 2014 - ajmsjournal.info
Objectives: To compare the efficacy of add on therapy of Vildagliptin versus Pioglitazone
among Type 2 Diabetes Mellitus patients inadequately controlled on dual therapy of …

[HTML][HTML] Efficacy and safety of a fixed-dose combination of vildagliptin and pioglitazone in Indian patients with type 2 diabetes mellitus: a randomized, open-label …

S Erande, J Mukhopadhyay, A Dange, A Deogaonkar… - Cureus, 2023 - ncbi.nlm.nih.gov
Background Type 2 diabetes mellitus (T2DM) arises due to a range of pathological
abnormalities, necessitating a combination therapy to achieve optimal glycemic control …

Comparative study: Efficacy and tolerability of vildagliptin vs. pioglitazone as an add-on therapy to metformin in poorly controlled type 2 diabetes mellitus patients in …

A Jindal, R Kaur, M Jindal - International Archives of …, 2015 - search.ebscohost.com
Introduction: The incidence of diabetes in urban Punjab is on the rise and the number of
diabetics is increasing year by year. Material and methods: This 24 week study was …

A comparative study to assess safety and efficacy of vildagliptin and metformin with glimepiride and metformin among type 2 diabetes patients

I Ahmed, Z Ali, MAR Afridi, SS Ali, M Nawaz… - Journal of Postgraduate …, 2021 - jpmi.org.pk
Objective: To assess the safety and efficacy of Vildagliptin with metformin and Glimepiride
with metformin among Type 2 Diabetes Mellitus (T2DM) patients with inadequate glycemic …

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes …

P Ved, S Shah - Indian journal of endocrinology and metabolism, 2012 - journals.lww.com
Objective: Addition of vildagliptin to ongoing insulin therapy may help in terms of overall
glycemic control as well as reduction in dose of insulin and weight. This study sought to …

Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin …

AR Hong, J Lee, EJ Ku, Y Hwangbo, KM Kim… - Diabetes Research and …, 2015 - Elsevier
The aim of present study is to compare the efficacy and safety of adding vildagliptin with
sulfonylurea dose-increasing as an active comparator in patients who had inadequately …

Evaluation of vildagliptin and fixed dose combination of vildagliptin and metformin on glycemic control and insulin dose over 3 months in patients with type 2 diabetes …

P Ved, S Shah - Indian Journal of Endocrinology and Metabolism, 2013 - journals.lww.com
We thank Mundra for a detailed analysis of our paper, and for his attempt to improve the
impact of our findings.[1] In our study, 152 subjects were on plain Vildagliptin while 148 were …

Comparison of Safety and Efficacy of Glimepiride-Metformin and Vildagliptin-Metformin Treatment in Newly Diagnosed Type 2 Diabetic Patients.

JK Mokta, AK Sahai, PK Kaundal… - The Journal of the …, 2018 - europepmc.org
Objectives To compare the safety and efficacy of combination of Glimepiride-Metformin with
Vildagliptin-Metformin in type 2 diabetic patients with HbA1c between 7.5 to10. Methods A …

Combining Therapy of Vildagliptin with Metformin Improves Glycemic Control than Using Metformin Alone in The Treatment of Type 2 Diabetes Mellitus

HH Amin, HR Chaudhary - International Journal of Pharmaceutical …, 2024 - ijpsdronline.com
The purpose of the trial was to determine whether combination medication for type 2
diabetes mellitus offers better glycemic control than monotherapy. Subjects whose ages …

[HTML][HTML] Effect of vildagliptin as add-on therapy to a low-dose metformin

C Filozof, S Schwartz, JE Foley - World journal of diabetes, 2010 - ncbi.nlm.nih.gov
AIM: To evaluate the efficacy and safety of the addition of vildagliptin to low-dose metformin
and compare it to an uptitration of metformin in type 2 diabetes mellitus (T2DM) patients who …